Literature DB >> 1341925

Cardiovascular effects on conscious rats of pretreatment with isoproterenol for 3 days.

J D Trindade1, A M Cabral, E C Vasquez, D V Vassallo.   

Abstract

The cardiovascular effect of isoproterenol pretreatment (ISO) mimicking short duration sympathetic hyperactivity was studied in conscious adult male albino rats. Cardiac hypertrophy of right and left ventricles was observed after pretreatment with isoproterenol for 3 days (0.1 mg/kg, 3 times a day), when compared to saline-treated rats. The pressor response to noradrenaline (NOR, 1 to 1000 micrograms/kg, iv) was slightly but consistently larger in the ISO group than in the control group (in mmHg, Control = 109 +/- 3.5; NOR 1 = 114 +/- 3.3; NOR 10 = 116 +/- 4; NOR 100 = 127 +/- 5.6 and NOR 1000 = 152 +/- 7.3 for saline-treated rats and, Control = 106 +/- 5.1; NOR 1 = 112 +/- 5.1; NOR 10 = 118 +/- 5.3; NOR 100 = 134 +/- 4.9 and NOR 1000 = 162 +/- 7.5 for ISO groups). An increased reflex bradycardia was also observed in response to increasing doses of noradrenaline (in bpm, Control = 323 +/- 5.6; NOR 1 = 313 +/- 6.8; NOR 10 = 309 +/- 8.6; NOR 100 = 293 +/- 7.5 and NOR 1000 = 284 +/- 5.3 for saline-treated rats and Control = 316 +/- 4.3; NOR 1 = 294 +/- 4.3; NOR 10 = 289 +/- 3.4; NOR 100 = 267 +/- 4 and NOR 1000 = 251 +/- 2.6 for ISO groups; ANOVa, P < 0.01). There were no significant differences in autonomic tone to the heart between control and isoproterenol-pretreated animals. The present results indicate that isoproterenol treatment induces significant in vivo cardiovascular modifications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341925

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  1 in total

1.  Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation.

Authors:  Ana Paula C Davel; Elisa Mitiko Kawamoto; Cristoforo Scavone; Dalton V Vassallo; Luciana V Rossoni
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.